Study of Demographic Profile, Comorbidities, Role of Hydroxychloroquine Prophylaxis and Outcomes of COVID-19 Positive Healthcare Workers at a Tertiary Care Center in Southern Rajasthan

Authors

  • Mahesh Dave Senior Professor and Unit Head, Dept. of General Medicine, RNT Medical College, Udaipur, Rajasthan, India
  • Manasvin Sareen Junior Resident (2nd Year), Dept. of General Medicine, RNT Medical College, Udaipur, Rajasthan, India
  • Yash Shah Junior Resident (1st Year), Dept. of General Medicine, RNT Medical College, Udaipur, Rajasthan, India
  • Sahil Kharbanda Junior Resident (2nd Year), Dept. of General Medicine, RNT Medical College, Udaipur, Rajasthan, India
  • Aniruddha Burli Junior Resident (3rd Year), Dept. of General Medicine, RNT Medical College, Udaipur, Rajasthan, India

Keywords:

COVID-19, healthcare workers, hydroxychloroquine

Abstract

Background: In December 2019, a new respiratory tract infecting agent emerged in Wuhan city of China, known as the coronavirus. There are limited studies regarding coronavirus disease 2019 (COVID-19) in healthcare workers (HCWs). Therefore, the present study was aimed to determine the demographic profile, comorbidities, hydroxychloroquine as prophylaxis and outcomes of reverse transcription polymerase chain reaction (RT-PCR) confirmed COVID-19 HCWs.
Material and methods: This study was an observational retrospective study carried out over a period of 10 months from 15th March, 2020 to 15th January, 2021 in 350 RT-PCR confirmed COVID-19 HCWs who were in home isolation or admitted in dedicated COVID hospital. Results: We observed that majority of HCWs were in the age group 20-39 years (66.58%), were males (69.14%) and from urban areas (72.86%). Only few had comorbidities (3.42%), took hydroxychloroquine as prophylaxis (5.71%) and mortality was 0.57%. About 46.29% of the HCWs were doctors and 28.40% of the doctors were
from Medicine. Conclusion: From the present study, we conclude that HCWs affected by COVID-19 are mainly young adult male physicians from urban areas, without significant comorbidities. The outcome in COVID-19 positive HCWs is favorable due to better awareness, prompt diagnosis and treatment. The results of this study will be useful in knowing the most vulnerable section of HCWs.

Additional Files

Published

2022-01-01

Issue

Section

Observational Study

Similar Articles

1-10 of 12

You may also start an advanced similarity search for this article.